The global leadless pacemakers market is anticipated to grow at a CAGR of 15.3% during the forecast period. The market growth is attributed to factors including the changing sedentary lifestyle, smoking, and excessive alcohol consumption attributed to the prevalence of bradycardia. According to a report titled “Bradycardia and Heart Rate Fluctuation Are Associated with a Prolonged Intensive Care Unit Stay in Patients with Severe COVID-19,” bradycardia was identified in 72.1% of the patients admitted to the intensive care unit at Chiang Mai University Hospital between April and June 2021. These health conditions often necessitate the use of Leadless Pacemakers to maintain an optimal heart rate. According to the Cleveland Clinic, in 2022, the prevalence of sinus bradycardia increased with age overall, impacting 1 in 600 cardiac patients over 65 years of age and 1 in 1000 persons over 45. Moreover, the significant burden of disease, high prevalence, and mortality rates are anticipated to propel the segment growth. In addition, the rising number of FDA approval also bolstering the leadless pacemakers market growth.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/leadless-pacemakers-market
- In July 2023, Abbott Laboratories received the US Food and Drug Administration (FDA) approval the AVEIR™ dual chamber (DR) leadless pacemaker system, the world’s first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms.
- In May 2023, Medtronic plc, a pioneer in healthcare technology, received US Food and Drug Administration (FDA) approval of its Micra™ AV2 and Micra™ VR2, the next generation of its industry-leading miniaturized, leadless pacemakers. Micra AV2 and Micra VR2, the world’s smallest pacemakers, provide longer battery life and easier programming than prior Micra pacemakers, while still delivering the many benefits of leadless pacing such as reduced complications compared to traditional pacemakers.
Global Leadless Pacemakers Market Report Segment
By Pacing Chamber
- Single Chamber
- Dual Chamber
By Product
- Micra Transcatheter Pacing System
- Nanostim Leadless Pacemaker
By End-User
- Hospitals
- Ambulatory Surgical Centers
- Other (Cardiac Centers)
A full report of Leadless Pacemakers Market available @ https://www.omrglobal.com/industry-reports/leadless-pacemakers-market
Leadless Pacemakers Market Report Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- BIOTRONIK SE & Co KG
- Beebe Healthcare
- EBR Systems Inc.,
- Lepu Medical Technology(Beijing)Co.,Ltd.
- LivaNova PLC
- OSYPKA MEDICAL GmbH
- Telectronics Pacing Systems, Inc.
- Terumo Corp.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
